0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Proteins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: June 2024
|
Report Code: QYRE-Auto-34G8837
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Proteins Market Size Status and Forecast 2022
BUY CHAPTERS

Global Recombinant Proteins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-34G8837
Report
June 2024
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Proteins Market Size

The global market for Recombinant Proteins was estimated to be worth US$ 975.8 million in 2023 and is forecast to a readjusted size of US$ 2320.6 million by 2030 with a CAGR of 13.0% during the forecast period 2024-2030.

Recombinant Proteins Market

Recombinant Proteins Market

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Recombinant Proteins Market Report

Report Metric Details
Report Name Recombinant Proteins Market
Forecasted market size in 2030 US$ 2320.6 million
CAGR 13.0%
Forecasted years 2024 - 2030
Segment by Type
  • Hormones
  • Growth Factors
  • Cytokines
  • Plasma Protein Factor
  • Recombinant Metabolic Enzymes
  • Immune Checkpoint Regulators
  • Others
Segment by Application
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Recombinant Proteins in global and regional level.
  • Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Proteins revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Recombinant Proteins Market size in 2030?

Ans: The Recombinant Proteins Market size in 2030 will be US$ 2320.6 million.

What is the market share of major companies in Recombinant Proteins Market?

Ans: The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%.

What is the Recombinant Proteins Market share by region?

Ans: In terms of market size, Asia Pacific is the largest consumption market with more than 35% share.

What is the Recombinant Proteins Market share by type?

Ans: In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively.

Who are the main players in the Recombinant Proteins Market report?

Ans: The main players in the Recombinant Proteins Market are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto

What are the Application segmentation covered in the Recombinant Proteins Market report?

Ans: The Applications covered in the Recombinant Proteins Market report are Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations

What are the Type segmentation covered in the Recombinant Proteins Market report?

Ans: The Types covered in the Recombinant Proteins Market report are Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, Others

1 Study Coverage
1.1 Recombinant Proteins Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Proteins Market Size Estimates and Forecasts
2.2 Recombinant Proteins Market Size by Region: 2023 Versus 2030
2.2.1 Global Recombinant Proteins Revenue by Region: 2019-2024
2.2.2 Global Recombinant Proteins Revenue Forecast by Region (2025-2030)
2.2.3 Global Recombinant Proteins Revenue Market Share by Region (2019-2030)
3 Global Recombinant Proteins by Company
3.1 Global Recombinant Proteins Revenue by Company (2019-2024)
3.2 Global Recombinant Proteins Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Recombinant Proteins Companies around the World: Ranking by Revenue
3.3.2 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Recombinant Proteins Companies Headquarters & Product Type
3.4.1 Recombinant Proteins Companies Headquarters
3.4.2 Global Recombinant Proteins Companies Product & Service
3.4.3 Date of International Companies Enter into Recombinant Proteins Market
3.5 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bio-Techne Corporation
4.1.1 Bio-Techne Corporation Company Information
4.1.2 Bio-Techne Corporation Description, Business Overview
4.1.3 Bio-Techne Corporation Recombinant Proteins Products Offered
4.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.1.5 Bio-Techne Corporation Recombinant Proteins Revenue by Product in 2023
4.1.6 Bio-Techne Corporation Recombinant Proteins Revenue by Application in 2023
4.1.7 Bio-Techne Corporation Recombinant Proteins Revenue by Geographic Area in 2023
4.1.8 Bio-Techne Corporation Recent Developments
4.2 Abcam PLC
4.2.1 Abcam PLC Company Information
4.2.2 Abcam PLC Description, Business Overview
4.2.3 Abcam PLC Recombinant Proteins Products Offered
4.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.2.5 Abcam PLC Recombinant Proteins Revenue by Product in 2023
4.2.6 Abcam PLC Recombinant Proteins Revenue by Application in 2023
4.2.7 Abcam PLC Recombinant Proteins Revenue by Geographic Area in 2023
4.2.8 Abcam PLC Recent Developments
4.3 Merck KGaA
4.3.1 Merck KGaA Company Information
4.3.2 Merck KGaA Description, Business Overview
4.3.3 Merck KGaA Recombinant Proteins Products Offered
4.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.3.5 Merck KGaA Recombinant Proteins Revenue by Product in 2023
4.3.6 Merck KGaA Recombinant Proteins Revenue by Application in 2023
4.3.7 Merck KGaA Recombinant Proteins Revenue by Geographic Area in 2023
4.3.8 Merck KGaA Recent Developments
4.4 Miltenyi Biotec
4.4.1 Miltenyi Biotec Company Information
4.4.2 Miltenyi Biotec Description, Business Overview
4.4.3 Miltenyi Biotec Recombinant Proteins Products Offered
4.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.4.5 Miltenyi Biotec Recombinant Proteins Revenue by Product in 2023
4.4.6 Miltenyi Biotec Recombinant Proteins Revenue by Application in 2023
4.4.7 Miltenyi Biotec Recombinant Proteins Revenue by Geographic Area in 2023
4.4.8 Miltenyi Biotec Recent Developments
4.5 Thermo Fisher Scientific
4.5.1 Thermo Fisher Scientific Company Information
4.5.2 Thermo Fisher Scientific Description, Business Overview
4.5.3 Thermo Fisher Scientific Recombinant Proteins Products Offered
4.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.5.5 Thermo Fisher Scientific Recombinant Proteins Revenue by Product in 2023
4.5.6 Thermo Fisher Scientific Recombinant Proteins Revenue by Application in 2023
4.5.7 Thermo Fisher Scientific Recombinant Proteins Revenue by Geographic Area in 2023
4.5.8 Thermo Fisher Scientific Recent Developments
4.6 ACROBiosystems
4.6.1 ACROBiosystems Company Information
4.6.2 ACROBiosystems Description, Business Overview
4.6.3 ACROBiosystems Recombinant Proteins Products Offered
4.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.6.5 ACROBiosystems Recombinant Proteins Revenue by Product in 2023
4.6.6 ACROBiosystems Recombinant Proteins Revenue by Application in 2023
4.6.7 ACROBiosystems Recombinant Proteins Revenue by Geographic Area in 2023
4.6.8 ACROBiosystems Recent Development
4.7 Sino Biological
4.7.1 Sino Biological Company Information
4.7.2 Sino Biological Description, Business Overview
4.7.3 Sino Biological Recombinant Proteins Products Offered
4.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.7.5 Sino Biological Recombinant Proteins Revenue by Product in 2023
4.7.6 Sino Biological Recombinant Proteins Revenue by Application in 2023
4.7.7 Sino Biological Recombinant Proteins Revenue by Geographic Area in 2023
4.7.8 Sino Biological Recent Development
4.8 Cytiva
4.8.1 Cytiva Company Information
4.8.2 Cytiva Description, Business Overview
4.8.3 Cytiva Recombinant Proteins Products Offered
4.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.8.5 Cytiva Recombinant Proteins Revenue by Product in 2023
4.8.6 Cytiva Recombinant Proteins Revenue by Application in 2023
4.8.7 Cytiva Recombinant Proteins Revenue by Geographic Area in 2023
4.8.8 Cytiva Recent Development
4.9 Eurogentec
4.9.1 Eurogentec Company Information
4.9.2 Eurogentec Description, Business Overview
4.9.3 Eurogentec Recombinant Proteins Products Offered
4.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.9.5 Eurogentec Recombinant Proteins Revenue by Product in 2023
4.9.6 Eurogentec Recombinant Proteins Revenue by Application in 2023
4.9.7 Eurogentec Recombinant Proteins Revenue by Geographic Area in 2023
4.9.8 Eurogentec Recent Development
4.10 GenScript Biotech Corporation
4.10.1 GenScript Biotech Corporation Company Information
4.10.2 GenScript Biotech Corporation Description, Business Overview
4.10.3 GenScript Biotech Corporation Recombinant Proteins Products Offered
4.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.10.5 GenScript Biotech Corporation Recombinant Proteins Revenue by Product in 2023
4.10.6 GenScript Biotech Corporation Recombinant Proteins Revenue by Application in 2023
4.10.7 GenScript Biotech Corporation Recombinant Proteins Revenue by Geographic Area in 2023
4.10.8 GenScript Biotech Corporation Recent Development
4.11 Reprocell
4.11.1 Reprocell Company Information
4.11.2 Reprocell Description, Business Overview
4.11.3 Reprocell Recombinant Proteins Products Offered
4.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.11.5 Reprocell Recombinant Proteins Revenue by Product in 2023
4.11.6 Reprocell Recombinant Proteins Revenue by Application in 2023
4.11.7 Reprocell Recombinant Proteins Revenue by Geographic Area in 2023
4.11.8 Reprocell Recent Development
4.12 BPS Bioscience
4.12.1 BPS Bioscience Company Information
4.12.2 BPS Bioscience Description, Business Overview
4.12.3 BPS Bioscience Recombinant Proteins Products Offered
4.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.12.5 BPS Bioscience Recombinant Proteins Revenue by Product in 2023
4.12.6 BPS Bioscience Recombinant Proteins Revenue by Application in 2023
4.12.7 BPS Bioscience Recombinant Proteins Revenue by Geographic Area in 2023
4.12.8 BPS Bioscience Recent Development
4.13 Abnova Corporation
4.13.1 Abnova Corporation Company Information
4.13.2 Abnova Corporation Description, Business Overview
4.13.3 Abnova Corporation Recombinant Proteins Products Offered
4.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.13.5 Abnova Corporation Recombinant Proteins Revenue by Product in 2023
4.13.6 Abnova Corporation Recombinant Proteins Revenue by Application in 2023
4.13.7 Abnova Corporation Recombinant Proteins Revenue by Geographic Area in 2023
4.13.8 Abnova Corporation Recent Development
4.14 ProSpec Tany TechnoGene
4.14.1 ProSpec Tany TechnoGene Company Information
4.14.2 ProSpec Tany TechnoGene Description, Business Overview
4.14.3 ProSpec Tany TechnoGene Recombinant Proteins Products Offered
4.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.14.5 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Product in 2023
4.14.6 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Application in 2023
4.14.7 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Geographic Area in 2023
4.14.8 ProSpec Tany TechnoGene Recent Development
4.15 Ajinomoto
4.15.1 Ajinomoto Company Information
4.15.2 Ajinomoto Description, Business Overview
4.15.3 Ajinomoto Recombinant Proteins Products Offered
4.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin (2019-2024)
4.15.5 Ajinomoto Recombinant Proteins Revenue by Product in 2023
4.15.6 Ajinomoto Recombinant Proteins Revenue by Application in 2023
4.15.7 Ajinomoto Recombinant Proteins Revenue by Geographic Area in 2023
4.15.8 Ajinomoto Recent Development
5 Breakdown Data by Type
5.1 Global Recombinant Proteins Revenue by Type (2019-2024)
5.2 Global Recombinant Proteins Revenue Forecast by Type (2025-2030)
5.3 Recombinant Proteins Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Recombinant Proteins Revenue by Application (2019-2024)
6.2 Global Recombinant Proteins Revenue Forecast by Application (2025-2030)
6.3 Recombinant Proteins Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Recombinant Proteins Market Size YoY Growth 2019-2030
7.2 North America Recombinant Proteins Market Facts & Figures by Country (2019-2030)
7.3 North America Recombinant Proteins Revenue by Type (2019-2024)
7.4 North America Recombinant Proteins Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Recombinant Proteins Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Recombinant Proteins Revenue by Type (2019-2024)
8.4 Asia-Pacific Recombinant Proteins Revenue by Application (2019-2024)
9 Europe
9.1 Europe Recombinant Proteins Market Size YoY Growth 2019-2030
9.2 Europe Recombinant Proteins Market Facts & Figures by Country (2019-2030)
9.3 Europe Recombinant Proteins Revenue by Type (2019-2024)
9.4 Europe Recombinant Proteins Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Recombinant Proteins Market Size YoY Growth 2019-2030
10.2 Latin America Recombinant Proteins Market Facts & Figures by Country (2019-2030)
10.3 Latin America Recombinant Proteins Revenue by Type (2019-2024)
10.4 Latin America Recombinant Proteins Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Recombinant Proteins Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Recombinant Proteins Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Recombinant Proteins Revenue by Type (2019-2024)
11.4 Middle East and Africa Recombinant Proteins Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Recombinant Proteins Supply Chain Analysis
12.2 Recombinant Proteins Key Raw Materials and Upstream Suppliers
12.3 Recombinant Proteins Clients Analysis
12.4 Recombinant Proteins Sales Channel and Sales Model Analysis
12.4.1 Recombinant Proteins Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Recombinant Proteins Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Recombinant Proteins Distributors
13 Market Dynamics
13.1 Recombinant Proteins Industry Trends
13.2 Recombinant Proteins Market Drivers
13.3 Recombinant Proteins Market Challenges
13.4 Recombinant Proteins Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Companies of Hormones
    Table 3. Major Companies of Growth Factors
    Table 4. Major Companies of Cytokines
    Table 5. Major Companies of Plasma Protein Factor
    Table 6. Major Companies of Recombinant Metabolic Enzymes
    Table 7. Major Companies of Immune Checkpoint Regulators
    Table 8. Major Companies of Others
    Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Recombinant Proteins Market Size by Region (US$ Million): 2023 VS 2030
    Table 11. Global Recombinant Proteins Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Recombinant Proteins Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 13. Recombinant Proteins Revenue by Company (2019-2024) & (US$ Million)
    Table 14. Recombinant Proteins Revenue Share by Company (2019-2024)
    Table 15. Ranking of Global Top Recombinant Proteins Players by Revenue (US$ Million) in 2023
    Table 16. Global Recombinant Proteins Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 17. Global Recombinant Proteins by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2023)
    Table 18. Global Recombinant Proteins Companies Headquarters
    Table 19. Global Recombinant Proteins Companies Product & Service
    Table 20. Date of International Companies Enter into Recombinant Proteins Market
    Table 21. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
    Table 22. Bio-Techne Corporation Company Information
    Table 23. Bio-Techne Corporation Description and Business Overview
    Table 24. Bio-Techne Corporation Recombinant Proteins Product
    Table 25. Bio-Techne Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 26. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 27. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 28. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 29. Bio-Techne Corporation Recent Development
    Table 30. Abcam PLC Company Information
    Table 31. Abcam PLC Description and Business Overview
    Table 32. Abcam PLC Recombinant Proteins Product
    Table 33. Abcam PLC Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 34. Abcam PLC Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 35. Abcam PLC Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 36. Abcam PLC Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 37. Abcam PLC Recent Development
    Table 38. Merck KGaA Company Information
    Table 39. Merck KGaA Description and Business Overview
    Table 40. Merck KGaA Recombinant Proteins Product
    Table 41. Merck KGaA Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 42. Merck KGaA Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 43. Merck KGaA Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 44. Merck KGaA Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 45. Merck KGaA Recent Development
    Table 46. Miltenyi Biotec Company Information
    Table 47. Miltenyi Biotec Description and Business Overview
    Table 48. Miltenyi Biotec Recombinant Proteins Product
    Table 49. Miltenyi Biotec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 50. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 51. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 52. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 53. Miltenyi Biotec Recent Development
    Table 54. Thermo Fisher Scientific Company Information
    Table 55. Thermo Fisher Scientific Description and Business Overview
    Table 56. Thermo Fisher Scientific Recombinant Proteins Product
    Table 57. Thermo Fisher Scientific Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 58. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 59. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 60. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 61. Thermo Fisher Scientific Recent Development
    Table 62. ACROBiosystems Company Information
    Table 63. ACROBiosystems Description and Business Overview
    Table 64. ACROBiosystems Recombinant Proteins Product
    Table 65. ACROBiosystems Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 66. ACROBiosystems Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 67. ACROBiosystems Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 68. ACROBiosystems Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 69. ACROBiosystems Recent Development
    Table 70. Sino Biological Company Information
    Table 71. Sino Biological Description and Business Overview
    Table 72. Sino Biological Recombinant Proteins Product
    Table 73. Sino Biological Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 74. Sino Biological Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 75. Sino Biological Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 76. Sino Biological Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 77. Sino Biological Recent Development
    Table 78. Cytiva Company Information
    Table 79. Cytiva Description and Business Overview
    Table 80. Cytiva Recombinant Proteins Product
    Table 81. Cytiva Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 82. Cytiva Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 83. Cytiva Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 84. Cytiva Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 85. Cytiva Recent Development
    Table 86. Eurogentec Company Information
    Table 87. Eurogentec Description and Business Overview
    Table 88. Eurogentec Recombinant Proteins Product
    Table 89. Eurogentec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 90. Eurogentec Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 91. Eurogentec Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 92. Eurogentec Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 93. Eurogentec Recent Development
    Table 94. GenScript Biotech Corporation Company Information
    Table 95. GenScript Biotech Corporation Description and Business Overview
    Table 96. GenScript Biotech Corporation Recombinant Proteins Product
    Table 97. GenScript Biotech Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 98. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 99. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 100. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 101. GenScript Biotech Corporation Recent Development
    Table 102. Reprocell Company Information
    Table 103. Reprocell Description and Business Overview
    Table 104. Reprocell Recombinant Proteins Product
    Table 105. Reprocell Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 106. Reprocell Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 107. Reprocell Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 108. Reprocell Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 109. Reprocell Recent Development
    Table 110. BPS Bioscience Company Information
    Table 111. BPS Bioscience Description and Business Overview
    Table 112. BPS Bioscience Recombinant Proteins Product
    Table 113. BPS Bioscience Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 114. BPS Bioscience Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 115. BPS Bioscience Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 116. BPS Bioscience Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 117. BPS Bioscience Recent Development
    Table 118. Abnova Corporation Company Information
    Table 119. Abnova Corporation Description and Business Overview
    Table 120. Abnova Corporation Recombinant Proteins Product
    Table 121. Abnova Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 122. Abnova Corporation Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 123. Abnova Corporation Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 124. Abnova Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 125. Abnova Corporation Recent Development
    Table 126. ProSpec Tany TechnoGene Company Information
    Table 127. ProSpec Tany TechnoGene Description and Business Overview
    Table 128. ProSpec Tany TechnoGene Recombinant Proteins Product
    Table 129. ProSpec Tany TechnoGene Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 130. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 131. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 132. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 133. ProSpec Tany TechnoGene Recent Development
    Table 134. Ajinomoto Company Information
    Table 135. Ajinomoto Description and Business Overview
    Table 136. Ajinomoto Recombinant Proteins Product
    Table 137. Ajinomoto Recombinant Proteins Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 138. Ajinomoto Revenue Proportion of Recombinant Proteins by Product in 2023
    Table 139. Ajinomoto Revenue Proportion of Recombinant Proteins by Application in 2023
    Table 140. Ajinomoto Revenue Proportion of Recombinant Proteins by Geographic Area in 2023
    Table 141. Ajinomoto Recent Development
    Table 142. Global Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 143. Global Recombinant Proteins Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 144. Global Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 145. Global Recombinant Proteins Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 146. North America Recombinant Proteins Revenue by Country (2019-2024) & (US$ Million)
    Table 147. North America Recombinant Proteins Revenue by Country (2025-2030) & (US$ Million)
    Table 148. North America Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 149. North America Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 150. Asia-Pacific Recombinant Proteins Revenue by Region (2019-2030) & (US$ Million)
    Table 151. Asia-Pacific Recombinant Proteins Revenue by Region (2025-2030) & (US$ Million)
    Table 152. Asia-Pacific Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 153. Asia-Pacific Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 154. Europe Recombinant Proteins Revenue by Country (2019-2024) & (US$ Million)
    Table 155. Europe Recombinant Proteins Revenue by Country (2025-2030) & (US$ Million)
    Table 156. Europe Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 157. Europe Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 158. Latin America Recombinant Proteins Revenue by Country (2019-2024) & (US$ Million)
    Table 159. Latin America Recombinant Proteins Revenue by Country (2025-2030) & (US$ Million)
    Table 160. Latin America Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 161. Latin America Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 162. Middle East and Africa Recombinant Proteins Revenue by Country (2019-2024) & (US$ Million)
    Table 163. Middle East and Africa Recombinant Proteins Revenue by Country (2025-2030) & (US$ Million)
    Table 164. Middle East and Africa Recombinant Proteins Revenue by Type (2019-2024) & (US$ Million)
    Table 165. Middle East and Africa Recombinant Proteins Revenue by Application (2019-2024) & (US$ Million)
    Table 166. Recombinant Proteins Key Raw Materials, Industry Status and Trend
    Table 167. Recombinant Proteins Key Raw Materials and Upstream Suppliers
    Table 168. Recombinant Proteins Clients Status and Trend
    Table 169. Recombinant Proteins Typical Clients
    Table 170. Recombinant Proteins Distributors
    Table 171. Recombinant Proteins Market Trends
    Table 172. Recombinant Proteins Market Drivers
    Table 173. Recombinant Proteins Market Challenges
    Table 174. Recombinant Proteins Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Proteins Product Picture
    Figure 2. Global Recombinant Proteins Revenue Market Share by Type in 2023 & 2030
    Figure 3. Hormones Product Picture
    Figure 4. Growth Factors Product Picture
    Figure 5. Cytokines Product Picture
    Figure 6. Plasma Protein Factor Product Picture
    Figure 7. Recombinant Metabolic Enzymes Product Picture
    Figure 8. Immune Checkpoint Regulators Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Recombinant Proteins Revenue Market Share by Application in 2023 & 2030
    Figure 11. Biopharmaceutical Companies
    Figure 12. Academic and Research Institutes
    Figure 13. Contract Research Organizations
    Figure 14. Recombinant Proteins Report Years Considered
    Figure 15. Global Recombinant Proteins Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Recombinant Proteins Market Size 2019-2030 (US$ Million)
    Figure 17. Global Recombinant Proteins Market Size Market Share by Region: 2023 Versus 2030
    Figure 18. Global Recombinant Proteins Revenue Market Share by Region (2019-2030)
    Figure 19. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Recombinant Proteins Revenue Market Share Forecast by Type (2019-2030)
    Figure 21. Global Recombinant Proteins Revenue Market Share Forecast by Application (2019-2030)
    Figure 22. North America Recombinant Proteins Revenue 2019-2030 (US$ Million)
    Figure 23. North America Recombinant Proteins Revenue Market Share by Type (2019-2024)
    Figure 24. North America Recombinant Proteins Revenue Market Share by Application (2019-2024)
    Figure 25. Asia-Pacific Recombinant Proteins Revenue 2019-2030 (US$ Million)
    Figure 26. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2019-2030)
    Figure 27. Asia-Pacific Recombinant Proteins Revenue Market Share by Type (2019-2024)
    Figure 28. Asia-Pacific Recombinant Proteins Revenue Market Share by Application (2019-2024)
    Figure 29. Europe Recombinant Proteins Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 30. Europe Recombinant Proteins Revenue Market Share by Country (2019-2030)
    Figure 31. Europe Recombinant Proteins Revenue Market Share by Type (2019-2024)
    Figure 32. Europe Recombinant Proteins Revenue Market Share by Application (2019-2024)
    Figure 33. Latin America Recombinant Proteins Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 34. Latin America Recombinant Proteins Revenue Market Share by Country (2019-2024)
    Figure 35. Latin America Recombinant Proteins Revenue Market Share by Type (2019-2024)
    Figure 36. Latin America Recombinant Proteins Revenue Market Share by Application (2019-2024)
    Figure 37. Middle East and Africa Recombinant Proteins Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 38. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2019-2030)
    Figure 39. Middle East and Africa Recombinant Proteins Revenue Market Share by Type (2019-2024)
    Figure 40. Middle East and Africa Recombinant Proteins Revenue Market Share by Application (2019-2024)
    Figure 41. Recombinant Proteins Supply Chain (Upstream and Downstream Market)
    Figure 42. Global Production Market Share of Recombinant Proteins Raw Materials by Region in 2023
    Figure 43. Recombinant Proteins Distribution Channels
    Figure 44. Global Recombinant Proteins Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 45. Global Recombinant Proteins Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
    Figure 49. Global Recombinant Proteins Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T19555
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30T17927
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L19449
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Add to Cart